Skip to Content
Merck
  • Mismatched perfusion defects secondary to recent methyl methacrylate embolization.

Mismatched perfusion defects secondary to recent methyl methacrylate embolization.

Clinical nuclear medicine (2012-12-18)
Garima Agrawal, Chadwick L Wright, Nicholas G Rhodes, Akash Sharma
ABSTRACT

Methyl methacrylate (MMA) pulmonary embolism is a serious potential complication of percutaneous vertebroplasty. We present a case of a 28-year-old man who presented to an outside institution with pleuritic chest pain after MMA vertebroplasty of the T11 thoracic vertebra for chronic back ache secondary to a previous traumatic fracture. Multifocal MMA pulmonary embolism was identified on CT. The patient was referred to our institution following a wedge resection for pulmonary infarction. V/Q scintigraphy was performed and demonstrated normal ventilation with multiple mismatched perfusion defects bilaterally. Patient subsequently underwent central and bilateral segmental pulmonary embolectomies.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Methyl methacrylate, 99%, stabilized
Supelco
Methyl methacrylate solution, certified reference material, 1000 μg/mL in methanol
Sigma-Aldrich
Methyl methacrylate, contains ≤30 ppm MEHQ as inhibitor, 99%